Sun Phar­ma buys out Con­cert, and its alope­cia drug, for $576M

Con­cert Phar­ma­ceu­ti­cals and its alope­cia drug have found a new home.

Mum­bai-based Sun Phar­ma an­nounced ear­ly Thurs­day that it will ac­quire Con­cert for $576 mil­lion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER